[Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 2006; 36(1): 48-55.10.1016/j.hepres.2006.06.004]Search in Google Scholar
[McKillop IH, Moran DM, Jin X, Koniaris LG. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 2006; 136(1): 125-135.10.1016/j.jss.2006.04.013]Search in Google Scholar
[Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005; 42(4): 809-818.10.1002/hep.20878]Search in Google Scholar
[Panga R, Tsea E, Poon RTP. Molecular pathways in hepatocellular carcinoma. Cancer Lett 2006; 240(2): 157-169.10.1016/j.canlet.2005.08.031]Search in Google Scholar
[Hsiang C-Y, Wu S-L, Chen J-C, Lo H-Y, Li C-C, Chiang S-Y, Wu H-C, Ho T-Y. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-κB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential. Toxicol Lett 2007; 171(1-2): 78-86.10.1016/j.toxlet.2007.04.009]Search in Google Scholar
[Djordjević D, Nikolić J, Stefanović V. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens. Pathol Biol 1998; 46(10): 760-70.]Search in Google Scholar
[Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10(3):185-200.10.1006/scbi.2000.0319]Search in Google Scholar
[Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007; 27(1): 55-76.10.1055/s-2006-960171]Search in Google Scholar
[Nishimura T, Nishida N, Komeda T, Fukuda Y, Ikai I, Yamaoka Y, Nakao K. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses. Cancer Genet Cytogenet 2006; 167(1): 57-65.10.1016/j.cancergencyto.2005.09.002]Search in Google Scholar
[Buendia, MA. Tumor suppressors in hepatocellular carcinoma: many are called, but few are chosen. J Hepatol 2007; 46(4): 546-548.10.1016/j.jhep.2007.01.005]Search in Google Scholar
[Pogribny IP, James SJ. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Cancer Lett 2002; 176(2): 169-174.10.1016/S0304-3835(01)00748-0]Search in Google Scholar
[Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thogeirsson SS. Activation of the canonical Wnt/β-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J Hepatol 2005; 42(6):842-849.10.1016/j.jhep.2005.01.029]Search in Google Scholar
[Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV. Immune pathogenesis of hepatocellular carcinoma. J Exp Med 1998; 188(2): 341-350.10.1084/jem.188.2.341]Search in Google Scholar
[Li B, Gao B, Ye L, Han X, Wang W, Kong L, Fang X, Zeng Y, Zheng H, Li S, Wu Z, Ye L. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res 2007; 124(1-2): 44-49.10.1016/j.virusres.2006.09.011]Search in Google Scholar
[Cougot D, Neuveut C, Buendia MA. HBV-induced carcinogenesis. J Clin Virol 2005; 34(Suppl 1): S75-S78.10.1016/S1386-6532(05)80014-9]Search in Google Scholar
[Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006; 147(2): 58-66.10.1016/j.lab.2005.10.00316459163]Search in Google Scholar
[Cha C, DeMatteo RP. Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol 2005; 19(1): 25-37.10.1016/j.bpg.2004.11.00515757803]Search in Google Scholar
[Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 2006; 239(1): 10-20.10.1016/j.canlet.2005.07.00916154256]Search in Google Scholar
[Wei W, Huang W, Pan Y, Zhu F, Wu J. Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett 2006; 244(1): 119-128.10.1016/j.canlet.2005.12.00816569476]Search in Google Scholar
[Kang-Park S, Lee JH, Shin JH, Lee YI. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings. Biochem Biophys Res Commun 2001; 283(2): 303-307.10.1006/bbrc.2001.476711327698]Search in Google Scholar
[Kang-Park S, Im JH, Lee JH, Lee YI. PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells. Virus Res 2006; 122(1-2): 53-60.10.1016/j.virusres.2006.06.01016872708]Search in Google Scholar
[Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, Koshy R, King IA. Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 2001; 82: 871-882.10.1099/0022-1317-82-4-871]Search in Google Scholar
[Kim KM, Kwon S-N, Kang J-I, Lee SH, Jang SK, Ahn B-Y, Kim YK. Hepatitis C virus NS2 protein activates cellular cyclic AMP-dependent pathways. Biochem Biophys Res Commun 2007; 356(4): 948-954.10.1016/j.bbrc.2007.03.070]Search in Google Scholar
[Baek K-H, Park H-Y, Kang C-M, Kim S-J, Jeong S-J, Hong E-K, Park J-W, Sung Y-C, Suzuki T, Kim C-M, Lee C-W. Overexpression of hepatitis C birus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation. J Mol Biol 2006; 359(1): 22-34.10.1016/j.jmb.2006.03.020]Search in Google Scholar
[Wang J, Tong W, Zhang X, Chen L, Yi Z, Pan T, Hu Y, Xiang L, Yuan Z. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells. FEBS Lett 2006; 580(18): 4392-4400.10.1016/j.febslet.2006.07.002]Search in Google Scholar
[Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 2006; 349(2): 347-358.10.1016/j.virol.2006.02.023]Search in Google Scholar
[Nguyen H, Sankaran S, Dandekar S. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology 2006; 354(1): 58-68.10.1016/j.virol.2006.04.028]Search in Google Scholar
[Wang J-S, Groopman JD. DNA damage by mycotoxins. Mutat Res 1999; 424(1-2): 167-181.10.1016/S0027-5107(99)00017-2]Search in Google Scholar
[Jackson PE, Groopman JD. Aflatoxin and liver cancer. Bailliere's Clin Gastroenterol 1999; 13(4): 545-555.10.1053/bega.1999.004710654919]Search in Google Scholar
[Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, Sun Z. Dominant Role of Hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002; 36(5): 1214-1220.10.1053/jhep.2002.3636612395332]Search in Google Scholar
[Asare GA, Bronz M, Naidoo V, Kew MC. Interactions between aflatoxin B1 and dietary iron overload in hepatic mutagenesis. Toxicology 2007; 234(3): 157-166.10.1016/j.tox.2007.02.00917399882]Search in Google Scholar
[Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127(5): S87-S96.10.1053/j.gastro.2004.09.020]Search in Google Scholar
[Balasubramaniyan V, Shukla R, Murugaiyan G, Bhonde RR, Nalini N. Mouse recombinant leptin protects human hepatoma HepG2 against apoptosis, TNF-α response and oxidative stress induced by the hepatotoxin-ethanol. Biochim Biophys Acta 2007; 1770(8): 1136-1144.10.1016/j.bbagen.2007.04.009]Search in Google Scholar
[Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34(1): 1-10.10.1016/S0891-5849(02)01167-X]Search in Google Scholar
[McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35(3): 195-203.10.1016/j.alcohol.2005.04.00416054981]Search in Google Scholar